Two-year prospective study of major depressive disorder in HIV-infected men

Atkinson, J. Hampton; Heaton, Robert K.; Patterson, Thomas L.; Wolfson, Tanya; Deutsch, Reena; Brown, Stephen J.; Summers, Jeffrey T.; Sciolla, Andrés F; Gutierrez, Rosben; Ellis, Ronald J.; Abramson, Ian; Hesselink, John R.; McCutchan, J. Allen; Grant, Igor

doi:10.1016/j.jad.2007.10.017

Cited by 97 publications

(88 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Cognitive slowing may be a result of the disease process or may be secondary to depression. Another consequence may be HIV-associated dementia, with accompanying characteristics of irritability, aggression or psychosis (Atkinson, 2008).…”

Section: Hiv/aids and Mental Illnessmentioning

confidence: 99%

“…Individually, these factors have profound mental-health ramifications, but, collectively, they serve as barriers to effective interventions. Consequently, clinicians and program planners must recognize that HIV/AIDS can severely impact an individual's health and mental-health status (UNAIDS, 2008) and that psychiatric disorders and symptoms are very common among at-risk and HIV-infected individuals (Harris, 1995;Atkinson et al, 2008).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Mental Health of Caribbean Women with HIV/AIDS

Baird¹,

Jones²,

Martin³

et al. 2012

PSYCH

View full text Add to dashboard Cite

Section: Hiv/aids and Mental Illnessmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Mental Health of Caribbean Women with HIV/AIDS

Baird¹,

Jones²,

Martin³

et al. 2012

PSYCH

View full text Add to dashboard Cite

“…Some studies have noted that the rate of mental illness is elevated among individuals who are HIV positive. For example, Atkinson, Heaton, Patterson, et al [7] found that patients who experience HIV-related symptoms are more likely to have a major depressive episode compared to individuals who are asymptomatic or are not infected with HIV. Pence, Miller, Whetten, Eron, and Gaynes [8] found that 39% of HIV positive clinic patients had a mood or anxiety disorder, 21% had a substance use disorder, and 8% had both a mood/anxiety and a substance use disorder.…”

Section: Hiv Prevalence Among Individuals With a Severe Mental Illnessmentioning

confidence: 99%

HIV, STD, and Sexual Risk Reduction for Individuals with a Severe Mental Illness: Review of the Intervention Literature

Senn¹,

Carey²

2008

CPSR

View full text Add to dashboard Cite

Seroprevalence studies indicate that HIV infection rates are elevated among individuals with a severe mental illness (SMI) compared to the general population. The higher prevalence of HIV among individuals with SMI has prompted the development and evaluation of tailored sexual risk reduction programs for these individuals. In this paper, we review the literature on sexual risk-reduction interventions for individuals with SMI, including interventions for both uninfected and infected individuals. We discuss components of successful interventions, identify limitations in the current literature, and highlight directions for future research. Finally, we conclude with implications for clinical practice, including a discussion of the challenges and advantages to implementing sexual risk reduction interventions for individuals with SMI.

show abstract

“…In both the pre and post HAART era, depression as well as other disorders of anxiety and dysthymia are common. [6][7][8] Despite the high prevalence of depression and depressive symptoms among HIV-infected persons, these conditions remain under-diagnosed. 9,10 For these individuals, the consequences of unrecognized and untreated depression can be significant and include increased mortality, diminished quality of life, and impaired adherence to antiretroviral therapy.…”

mentioning

confidence: 99%

Sadness in the SUN: Using Computerized Screening to Analyze Correlates of Depression and Adherence in HIV-Infected Adults in the United States

Tedaldi

Berg-Wolf

Richardson

et al. 2012

AIDS Patient Care and STDs

View full text Add to dashboard Cite

We used a standardized screening tool to examine frequency of depression and its relation to antiretroviral medication adherence among HIV-infected persons on highly active antiretroviral therapy (HAART) in the Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study). This is a prospective observational cohort of 700 HIV-infected patients enrolled between March 2004 and June 2006 in four U.S. cities, who completed a confidential audio computer-assisted self-interview [ACASI] with behavioral risk and health-related questions at baseline and 6-month follow-up visits, including the nine-question PRIME-MD depression screener and a validated 3-day antiretroviral adherence question. Among 539 eligible participants receiving HAART, 14% had depression at baseline (22% women, 12% men). In multivariable analysis using generalized estimating equations (GEE) to account for repeated measurements through 24 months of follow-up, persons who reported depression on a given ACASI were twice as likely to report nonadherence to antiretrovirals on the same ACASI (Odds ratio [OR] 2.02, 95% CI: 1.15, 3.57] for mild/moderate depression versus none); such persons were also less likely to have HIV viral load < 400 copies/mL. Self-administered computerized standardized screening tools can identify at-risk individuals with depression who may benefit from interventions to improve antiretroviral adherence.

show abstract

Two-year prospective study of major depressive disorder in HIV-infected men

Cited by 97 publications

References 30 publications

Mental Health of Caribbean Women with HIV/AIDS

Mental Health of Caribbean Women with HIV/AIDS

HIV, STD, and Sexual Risk Reduction for Individuals with a Severe Mental Illness: Review of the Intervention Literature

Sadness in the SUN: Using Computerized Screening to Analyze Correlates of Depression and Adherence in HIV-Infected Adults in the United States

Contact Info

Product

Resources

About